Home » Topics » BioWorld Science

BioWorld Science
RSS

IMV reports preliminary phase II data for DPX-Survivac in ovarian cancer

March 27, 2019

Phase II trial of Triplex for CMV complications in HSCT recipients meets primary endpoint

March 27, 2019

Revcovi approved in Japan for ADA deficiency

March 27, 2019

Boronated analogues of pleuromutilins show promise for filarial infections in vivo

March 27, 2019

FDA approves Mayzent for relapsing forms of MS

March 27, 2019

Progesterone found to predict prognosis of adrenocortical carcinoma

March 27, 2019

Rosuzet approved in Japan for hypercholesterolemia and familial hypercholesterolemia

March 27, 2019

AcuraStem patents 1-phosphatidylinositol 3-phosphate 5-kinase inhibitors

March 27, 2019

Amgen describes new Mcl-1 inhibitors

March 27, 2019

Lysophosphatidic acid receptor 1 antagonists identified at Lilly

March 27, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...